4//SEC Filing
Krause Kevin Michael 4
Accession 0001610717-24-000167
CIK 0001880438other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 7:28 PM ET
Size
18.2 KB
Accession
0001610717-24-000167
Insider Transaction Report
Form 4
Krause Kevin Michael
Chief Strategy Officer
Transactions
- Award
Common Stock
2024-03-15+30,000→ 31,914 total - Award
Stock Option (right to buy)
2024-03-15+60,000→ 60,000 totalExercise: $3.00Exp: 2034-03-14→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]These restricted stock units vest as follows: 1/16th of the shares vests quarterly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
- [F2]The shares subject to the option vest as follows: 1/48th of the shares vests monthly over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001916925
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 7:28 PM ET
- Size
- 18.2 KB